FDA

« Previous Entries

FDA Gives Approval to Aliqopa

Saturday, September 23rd, 2017

The FDA gave accelerated approval to Aliqopa (copanlisib) a few days ago. The drug is approved for treating adults having relapsed follicular lymphoma and who have undergone at minimum two treatments earlier, called systemic therapies. According to researchers, in case of relapsed follicular lymphoma patients, the cancer usually returns even after completing several treatments. These […]

FDA Recently Gave Approval to First Gene Therapy in The U.S.

Thursday, September 7th, 2017

On Aug 31st the FDA gave approval to Kymriah for treating certain patients, pediatric as well as young adults, suffering from a type of acute lymphoblastic leukemia. This is a landmark decision because now gene therapy is available in America for the first time. Cancer patients and people with other serious conditions will now have an […]

FDA Gives Approval to New Antibacterial Drug

Thursday, August 31st, 2017

The FDA has given approval to Vabomere for treating adults suffering with complicated urinary tract infection, including pyelonephritis. The latter is a kidney infection caused by particular bacteria. In addition to an antibacterial called meropenem, the drug Vabomere contains vaborbactam which is known for its ability to inhibit some particular types of resistance mechanisms that […]

FDA Gives Approval to Mavyert For Treating Hepatitis C

Friday, August 4th, 2017

The FDA has approved Mavyert for the treatment of adults having hepatitis C virus genotypes 1-6 with mild cirrhosis or without cirrhosis. This includes patients who suffer from a kidney disease, mild to severe, as well as dialysis patients. The drug is also indicated for patients above 18 years who have hepatitis C virus genotype […]

FDA Gives Approval to First Drug for Treating Giant Cell Arteries

Saturday, May 27th, 2017

The FDA has expanded the indication the use of subcutaneous tocilizumab for treating adults suffering from giant cell arteries. With this latest indication, tocilizumab becomes the first therapy approved by FDA for treating giant cell arteries. According to experts, approval of tocilizumab to treat giant cell arteries gives patients one additional option. At present, treatment […]

FDA approves Sitvarga for Treating Liver Cancer

Sunday, April 30th, 2017

The FDA has expanded the approved use of Sitvarga. Now this drug can be used for treating liver cancer patients who have had undergone treatment with sorafenib. The FDA has approved a new liver cancer treatment in almost ten years. Liver cancer patients don’t have many treatment options available to them. Now, for the first […]

FDA Gives Approval to Ingrezza for Tardive Dyskinesia

Wednesday, April 12th, 2017

The FDA has given approval to Ingrezza capsules for treating adults suffering from tardive dyskinesia. With this approval, Ingrezza capsules become the first drug to receive FDA’s approval for treating tardive dyskinesia. A neurological condition, tardive dyskinesia is characterized by involuntary jerky movements of the jaw and other body parts like the tongue and lips, […]

FDA Approves Ocrevus for Treating MS

Friday, March 31st, 2017

The FDA has given approval to Ocrevus for treating adults suffering from relapsing multiple sclerosis (or MS for short) and primary progressive multiple sclerosis (or PPMS for short). With this approval, Ocrevus has become the first drug that FDA has approved for treating PPMS. This drug is administered intravenously. MS is a chronic, autoimmune condition […]

FDA Gives Approval to Xermelo

Wednesday, March 1st, 2017

The FDA has given approval to Xermelo to be used along with SSA therapy for treating carcinoid syndrome diarrhoea in adults in whom SSA therapy alone couldn’t control the condition. Carcinoid tumour patients sometimes show a group of symptoms that are collectively known as Carcinoid syndrome. Carcinoid tumours occur rarely and don’t grow at a […]

FDA Gives Approval to a New Psoriasis Medication

Friday, February 17th, 2017

The FDA has given approval to Siliq for treating moderate and severe cases of plaque psoriasis in adults. The drug is administered through an injection. Siliq is approved for use in patients who are suitable for phototherapy or systemic therapy and have not responded to other systemic therapies. According to experts, approval of Siliq gives […]

« Previous Entries